Long COVID can cause more than 200 symptoms and it affects each person differently, according to a new report from the National Academies of Sciences, Engineering, and Medicine.

Community pharmacist–provided care for minor conditions could be cost-effective, new research shows.

Does taking the GLP-1 receptor agonist semaglutide for blood glucose control also lower the risk of clinically important kidney and cardiovascular outcomes? In the FLOW clinical trial, researchers found that of the 3,533 patients diagnosed with both T2D and chronic kidney disease, those taking semaglutide had a 24% lower risk of a primary-outcome event in the intervention group compared with the controls.

University of Florida Health has been awarded a stipend by CDC to run a program that aims to connect patients with high BP to community pharmacists.

CDC said last week that disruptions in health care access during the COVID-19 pandemic contributed to declining rates of routine immunizations among young children. In a new report, the agency said that uptake of state-mandated vaccines dropped somewhat in 2021–22 for kindergarteners.